Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Next Gen 2 by Bioprojet SCR for Narcolepsy: Likelihood of Approval
Next Gen 2 is under clinical development by Bioprojet SCR and currently in Phase I for Narcolepsy. According to GlobalData,...